Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (Q454783)

From MaRDI portal
Revision as of 19:03, 21 June 2023 by Importer (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control
scientific article

    Statements

    Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    10 October 2012
    0 references